BML Inc
Research BML Inc (BMZ) on Bullrun: market cap EUR 794.65M, P/E 17.5, dividend yield 1.7%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBMZ
- ExchangeMU
- CountryJapan
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyEUR
- Market capEUR 794.65M
- P/E17.5
- Dividend yield1.7%
- Financial periodFY2026
- RevenueJPY 150.26B
- Revenue growth4.9%
- Net incomeJPY 7.75B
- Free cash flowJPY 10.59B
- Gross margin32.4%
Valuation Snapshot
latest market cap is EUR 794.65M; P/E is 17.5; dividend yield is 1.7%.
Peer valuation comparison
Latest P/E is 17.52x versus a Healthcare sector median of 21.69x (19.2% below).
Latest dividend yield is 1.65% versus a Healthcare sector median of 2.41% (31.5% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | JPY 150.26B | JPY 7.75B | JPY 10.59B | 32.4% | n/a | JPY 68.03B | JPY 4.82B | JPY 127.67B |
| FY2025 | JPY 143.19B | JPY 6.26B | -JPY 849.00M | 32.0% | 160.55 | JPY 67.56B | JPY 5.29B | JPY 129.40B |
| FY2024 | JPY 137.96B | JPY 6.03B | -JPY 6.48B | 33.1% | 154.74 | JPY 74.11B | JPY 5.27B | JPY 125.86B |
| FY2023 | JPY 159.46B | JPY 15.58B | JPY 5.28B | 38.5% | 395.62 | JPY 86.52B | JPY 4.15B | JPY 122.49B |
| FY2022 | JPY 186.07B | JPY 33.74B | JPY 38.52B | 46.7% | 832.62 | JPY 92.13B | JPY 3.33B | JPY 116.20B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-14 | EUR 794.65M | 17.5 | 3.5% | 0.7 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.7 EUR, yield 1.7%.
| Year | Dividends/share |
|---|---|
| FY2026 | 0.36 JPY |
| FY2025 | 0.7 JPY |
| FY2024 | 0.49 JPY |
| FY2023 | 0.54 JPY |
| FY2022 | 0.68 JPY |
About BML Inc
BML, Inc. provides contract clinical testing and related services in Japan. The company offers routine laboratory testing, such as biochemical and hematologic examination; special laboratory test, including tumor markers, infectious diseases, hormones, cellular immunity, genetics, bacteriological tests, and other test;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is BML Inc's market cap?
BML Inc's market capitalization is EUR 794.65M.
What is BML Inc's P/E ratio?
BML Inc's price-to-earnings (P/E) ratio is 17.5.
Does BML Inc pay a dividend?
BML Inc has a dividend yield of 1.7%.
What does BML Inc do?
BML, Inc. provides contract clinical testing and related services in Japan. The company offers routine laboratory testing, such as biochemical and hematologic examination; special laboratory test, including tumor markers, infectious diseases, hormones, cellular immunity, genetics, bacteriological tests, and other test; specialized testing in oncology, infectious diseases, diabetes, hypertension, allergies, genetics, and more areas, as well as develops Frontier and Symphony automation systems, which automate pre-testing from specimen sorting to dispensing.